Pope Francis (Credit: X)
Pope Francis injured his right arm after suffering a fall earlier this week. According to the Vatican, while the 88-year-old pontiff did not break his arm, a sling was put on as a precaution. This incident comes just weeks after another fall on December 7, where he hit his chin on a nightstand, resulting in another, visible bruise. The pope's health has been a topic of ongoing speculation due to his age and medical history, which includes long bouts of bronchitis and mobility challenges. Often seen using a wheelchair or a cane, Francis also uses a walker within the Vatican's Santa Marta hotel, where he resides. Notably, his frailty has brought renewed attention to the risks of falls among elderly individuals and the steps one must follow to mitigate such falls.
A study published in Frontiers in Aging Neurosciences people get older, the bone density in the lower back and thigh bone decreases significantly. This raises the risk of osteoporosis (OP). Therefore it becomes pivotal to pay early attention to nutrition, exercise ability, vitamin D levels, and uric acid levels in older individuals to prevent Ostreopsis and mitigate fall risks. The risk of falls and bone injuries among elderly individuals underscores the importance of preventive measures for maintaining bone health and minimizing fall risks.
Elderly, particularly menopausal women, require a daily calcium intake of 1,200 mg, divided into two or more doses. This can be achieved through dietary sources such as dairy and non-dairy products or through supplements like calcium carbonate and calcium citrate. However, total daily calcium intake should not exceed 2,500 mg to avoid potential health risks.
Vitamin D is essential for calcium absorption and bone mineralization. While sunlight exposure helps synthesize vitamin D, older individuals often require supplements due to reduced skin synthesis and the limited availability of foods. Fortified milk and supplements containing 200–600 IU of vitamin D daily are recommended, with higher doses required for those with deficiencies. Severe cases may necessitate high-dose treatments, such as 50,000 IU weekly for up to three months, along with regular monitoring of calcium and vitamin D levels.
Regular exercise is vital for preserving bone mass and reducing fall risk. Weight-bearing activities, strength training, and balance exercises like brisk walking or skipping can enhance bone density and improve coordination. Experts recommend at least 30 minutes of moderate physical activity most days of the week, supplemented by strength training twice weekly. For individuals unable to engage in standard exercise routines, alternatives like vibrating platforms may help maintain bone health.
Falls remain a leading cause of fractures among individuals over 60. Addressing contributing factors such as balance issues, vision problems, and environmental hazards can significantly reduce risks. Preventive measures include regular vision checks, minimizing medications causing dizziness, improving home safety (e.g., installing railings and removing loose rugs), and wearing rubber-soled footwear. Hip protectors may also help mitigate the impact of falls.
Credits: GEMINI
President Trump's noticeably raspy voice drew attention during a meeting with the White House task force on the FIFA World Cup 2026 on Monday, when a reporter asked if he was feeling well. Trump replied, "I feel great. I was shouting at people because they were being foolish about something related to trade and a country, and I straightened it out, but I lost my temper with them." This has reignited discussions about Donald Trump's health.
Trump’s hoarse voice caught attention as he explained it came from raising his voice at foreign leaders over his favorite topic: trade and tariffs. He sounded a bit rough during a November 17 Oval Office event, where he spoke to reporters about the U.S. hosting plans for the 2026 FIFA World Cup, as per USA Today.
"I feel great," Trump said when asked about his raspy tone. "I was shouting at people because they were stupid about something to do with trade in a country, and I fixed it. But I lost my temper with them." He added, "A country tried to renegotiate the terms of their trade deal, and I wasn’t happy." When pressed on which country, Trump refused to answer, saying, "Why would I say that to you?"
Trump’s health has been under the microscope during his second term, particularly dark spots noticed on his hand, which he attributes to taking aspirin regularly and frequent handshakes. The White House reported he recently had an MRI as part of his annual physical, which Trump described as “standard,” though he admitted he did not know what exactly the doctors were reviewing, as per USA Today.
Earlier this year, it was also disclosed that Trump was diagnosed with a common vein condition, usually not serious with treatment, after he was seen with swollen ankles. At 79, Trump continues to insist his health is excellent.
Trump revealed he had an MRI scan, saying the doctor called it the “best result” they had ever seen in their career. When asked which part of his body was examined, he clarified that it was all part of a “routine annual” physical. “I had no idea what they analyzed, but whatever they analyzed, they analyzed it well,” he said.
In October, Trump told reporters he underwent an MRI at Walter Reed National Military Medical Center during a “very standard” checkup, describing it as routine. When asked if it involved his brain, he said, “Getting an MRI is very standard. What, you think I shouldn’t have it? Other people get it … I had an MRI. The doctor said it was the best result he has ever seen as a doctor.”
While traveling on Air Force One to Florida, the president added, “The other thing I did … as you know … was a very advanced test on mental acuity because I believe a president should do that, and as you probably heard, I aced it.”
Journalist Mehdi Hasan reacted on X, saying: “Donald Trump says he does not know why he had an MRI. How is this not 25th Amendment territory?”
MSNBC co-host Symone D. Sanders Townsend also wrote on X Friday: “This is not routine. Why did the President need an MRI?”
As this marked Trump’s second MRI, questions have emerged about his health. Initially, the White House described his visit to Walter Reed as a “routine yearly checkup,” even though he had already had his yearly physical in April. The president later referred to it as a “semiannual physical.”
Credits: Canva
The FDA on Friday revised the safety information for Sarepta Therapeutics’ Duchenne muscular dystrophy gene therapy, Elevidys, adding a boxed warning to alert patients and doctors about the risk of severe liver damage and possible death. This highest-level warning outlines the chance of serious liver injury and acute liver failure in people who receive Elevidys, with both complications carrying the possibility of being fatal.
The agency has also limited the therapy’s use to ambulatory Duchenne patients who are at least 4 years old and have a confirmed mutation in the DMD gene. With these changes, Elevidys is no longer permitted for patients who cannot walk.
Duchenne muscular dystrophy (DMD) is a serious inherited condition that leads to steady muscle weakening and loss, affecting boys far more often. It stems from a defect in the dystrophin gene, which prevents the body from making a key protein that protects muscle fibers.
Signs usually show up in early childhood and include trouble walking or climbing, frequent falls and a noticeable waddling walk, according to the Cleveland Clinic.
Gene therapy for Duchenne muscular dystrophy delivers a corrected or shortened form of the dystrophin gene into muscle cells using a modified virus. This allows the cells to produce a working version of the protein. The single intravenous infusion is designed to slow the disease by restoring some dystrophin, with the aim of improving movement and daily functioning. While the FDA has cleared a therapy that creates a reduced “micro-dystrophin,” researchers are still working on ways to provide the full-length gene for potentially stronger results, as noted by the Food and Drug Administration.
Elevidys is a gene-based treatment designed for Duchenne muscular dystrophy. It is given only once and relies on an adeno-associated virus to carry a modified form of the dystrophin gene into the body. This shorter micro-dystrophin version is meant to take the place of the faulty or absent dystrophin that leads to the condition.
The U.S. Food and Drug Administration is tightening control over a Duchenne muscular dystrophy gene therapy after two teenagers died from liver failure linked to the treatment. The agency has restricted Elevidys, made by Sarepta Therapeutics, to boys aged 4 and older who are still able to walk.
It can no longer be given to boys who have already lost the ability to move independently, something that usually occurs around age 12 in Duchenne. A safety review confirmed that both teenagers developed severe liver damage after receiving the infusion and later died.
The FDA is also adding its strongest boxed warning to call attention to the risks of serious liver injury, acute liver failure and death. Sarepta, based in Cambridge, Massachusetts, with offices in several countries, told regulators earlier this year that it had already stopped supplying the therapy to non-ambulatory patients. The company stated that Elevidys has been used in 1,100 patients worldwide.
These updates “will ensure that families and health-care professionals have clear information” to support treatment choices, Louise Rodino-Klapac, Sarepta’s head of research and development, told The New York Times.
The FDA’s new label comes at the end of a difficult year for Sarepta, marked by weak clinical trial results, safety questions surrounding Elevidys and declining sales.
Credits: Wikimedia Commons
Liev Schreiber, American actor, best known for his role in Spotlight, and latest seen at the Stranger Things promotional events alongside his daughter Kai Schreiber, was rushed to hospital on Sunday. The actor said that he was suffering from a "brutal headache".
The TMZ reported the health scare after he was being hospitalized in the New York City, and stayed overnight Sunday in the hospital on the advice of his doctor. The doctors have also run tests on him. However, his diagnosis still remains unclear, though as per the TMZ report, doctors have said to him that his ability to walk and speech has not be affected.
In April 2024, Schreiber revealed that he had a rare condition called transient global amnesia, while he was starring in Doubt: A Parable on Broadway during an appearance on Late Night with Seth Meyers.
“The worst nightmare that an actor could possibly ever experience. I was in my dressing room and I had a terrible headache. I thought it was maybe a fast-food headache, but it felt a little stronger than that. I am walking down the stairs, and I am thinking, 'This is not normal. I don't feel okay'," he said.
He said that his condition got worse when he was on stage, as he would completely forget his lines. "It all vanishes. The play is gone from my head...I know I am in a play, but I do not know what play I am in," he said.
He added, "My doctor, who’s a friend, shows up, and he had a terrified expression. My wife shows up, and she looks terrified. I think, ‘Okay, I’ve had a stroke. This is it.'” Although it was not a stroke, but the symptom of transient global amnesia, the actor did not believe it.
He recalled the doctor telling him that he may have the same experience again "it will be gone in 8 to 24 hours", however, he did not believe it. "You know, as a typical sort of Jewish hypochondriac person, I’m convinced that I had a stroke and they just didn’t find it," he said.
“I go to sleep, I wake up, I remember the whole play. I never had another problem with it. I was embarrassed and thought everyone would think I was lying and taking a night off from the theater,” he added.
Transient Global Amnesia or TGA is a sudden, temporary episode of confusion and memory loss, where a person cannot form new memories (anterograde amnesia) and may have trouble recalling recent past events (retrograde amnesia).
Individuals with TGA often repeatedly ask the same questions because they forget the answers, but they retain their sense of self and recognize close friends and family. Episodes are usually benign, resolve within 24 hours, and do not result in lasting neurological damage.
While the cause of transient global amnesia is not known, experts believe that there could be a link between TGA and a history of migraines. However, the factors that contribute in the link of these two conditions are still not fully understood.
© 2024 Bennett, Coleman & Company Limited